These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 400738)
1. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism. Wisgerhof M; Carpenter PC; Brown RD J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738 [TBL] [Abstract][Full Text] [Related]
2. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension. Wisgerhof M; Brown RD J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608 [TBL] [Abstract][Full Text] [Related]
3. Effect of bromocriptine treatment on the aldosterone response to angiotensin II and adrenocorticotropin in idiopathic hyperaldosteronism. Wisgerhof M; Mellinger RC J Clin Endocrinol Metab; 1985 Jul; 61(1):192-5. PubMed ID: 2987293 [TBL] [Abstract][Full Text] [Related]
4. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. Wisgerhof M; Brown RD; Hogan MJ; Carpenter PC; Edis AJ J Clin Endocrinol Metab; 1981 Feb; 52(2):195-8. PubMed ID: 7462385 [TBL] [Abstract][Full Text] [Related]
5. The acute effect of angiotensin II on adrenal and anterior pituitary function in normal subjects and subjects with primary hyperaldosteronism. Fraser R; Mason PA; Young J Prog Biochem Pharmacol; 1980; 17():14-9. PubMed ID: 6259651 [TBL] [Abstract][Full Text] [Related]
6. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure. Nicholls MG; Espiner EA; Donald RA J Lab Clin Med; 1976 Jun; 87(6):1005-15. PubMed ID: 180213 [TBL] [Abstract][Full Text] [Related]
7. 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism. Zoccali C; Usherwood T; Brown JJ; Lever AF; Robertson JI; Fraser R J Steroid Biochem; 1983 Jul; 19(1A):327-31. PubMed ID: 6310234 [TBL] [Abstract][Full Text] [Related]
8. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance. Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446 [TBL] [Abstract][Full Text] [Related]
9. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I. Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645 [TBL] [Abstract][Full Text] [Related]
10. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension. Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810 [TBL] [Abstract][Full Text] [Related]
11. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism. Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332 [TBL] [Abstract][Full Text] [Related]
12. Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension. Marks AD; Marks DB; Kanefsky TM; Adlin VE; Channick BJ J Clin Endocrinol Metab; 1979 Feb; 48(2):266-70. PubMed ID: 429480 [TBL] [Abstract][Full Text] [Related]
13. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II. Williams GH; Dluhy RG; Moore TJ Mayo Clin Proc; 1977 May; 52(5):312-6. PubMed ID: 870773 [TBL] [Abstract][Full Text] [Related]
14. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake. Carey RM; Vaughan ED; Peach MJ; Ayers CR J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631 [TBL] [Abstract][Full Text] [Related]
15. The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects. Wisgerhof M; Brown RD J Clin Endocrinol Metab; 1979 Jul; 49(1):107-9. PubMed ID: 447808 [TBL] [Abstract][Full Text] [Related]
16. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders. Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163 [TBL] [Abstract][Full Text] [Related]
17. Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone-producing adenoma. Nomura K; Toraya S; Horiba N; Ujihara M; Aiba M; Demura H J Clin Endocrinol Metab; 1992 Jul; 75(1):323-7. PubMed ID: 1619026 [TBL] [Abstract][Full Text] [Related]
18. Decreased vascular and increased adrenal and renal sensitivity to angiotensin II in the newborn lamb. Siegel SR Circ Res; 1981 Jan; 48(1):34-8. PubMed ID: 7002347 [TBL] [Abstract][Full Text] [Related]
19. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension]. Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950 [TBL] [Abstract][Full Text] [Related]
20. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus. Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]